The President of the Federal Institute for Drugs and Medical Devices (BfArM), Karl Broich, has criticized the increasing supply shortages of medicines as "completely unacceptable". In individual cases, certain cancer therapies would have to be interrupted or postponed, Broich told the “Frankfurter Allgemeine Zeitung” (Thursday edition). Overall, however, the bottlenecks are above all a problem for pharmacists, who would then have to look for replacement medication.
“The failures are increasing, that's very clear. But the delivery bottlenecks rarely have a serious impact on patients, ”the BfArM President continued. The Federal Institute for Drugs and Medical Devices, based in Bonn, collects voluntary reports about delivery bottlenecks for important medicines. Broich welcomed the fact that, according to the will of the Grand Coalition in Berlin, manufacturers should soon be obliged to report impending or acute bottlenecks. In addition, the decisions of the authority should be mandatory for the federal states. "That would help us a lot and it would be a step in the right direction," said the BfArM President. The main reason for delivery bottlenecks is the price pressure for certain drugs. This led to the formation of too many monopolies and oligopolies. You have to "counteract them wherever they exist", Broich told the "Frankfurter Allgemeine Zeitung". The "cheapest drugs" are "often too cheap." ()